Graham Erwin, Ph.D., is a Stanford Cancer Institute Postdoctoral Fellow with Professor Michael Snyder in the Department of Genetics at Stanford University. He is a molecular, chemical, and genome biologist elucidating the functional role of tandem repeat (TR) DNA sequences. This work is guiding the design of new therapeutics and diagnostics for human disease. Graham is currently supported by an NIH Pathway to Independence Award (K99/R00).
He received his Ph.D. in biochemistry from the University of Wisconsin–Madison with Professor Aseem Ansari, where he was a co-inventor of synthetic transcription factors to treat devastating neurodegenerative diseases. The resulting patents formed the basis of Design Therapeutics (Nasdaq: DSGN). He has published first-author papers in high-impact journals including PNAS and Science.
For the past two years, Graham has organized the Stanford Genetics Conference on Structural Variants and DNA Repeats (SVAR), a conference that he created. SVAR attracts more than 1,000 researchers each year to learn about the latest advances at the final frontier of the human genome.
As a first-generation college student, Graham is an advocate for first-generation college students from underrepresented backgrounds. He is a guest lecturer in Wellness Education at Stanford.